EVANSTON, Ill.--(BUSINESS WIRE)--Minute Molecular Diagnostics today announced that the U.S. Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for its rapid DASH ...
The FDA has issued its first emergency use authorization for a COVID-19 molecular diagnostic test that does not require a prescription and can be used at home. Developed by Cue Health, the Cue ...
After issuing an emergency use authorization (EUA) for the first antigen test for coronavirus disease (COVID-19) over the weekend, the US Food and Drug Administration (FDA) on Monday updated its EUA ...
3EO becomes the first point-of-care molecular technology to be retail priced below $15 per test. 3EO adds a breakthrough business model enabling more physician practices to upgrade technology from ...
SANTA BARBARA, Calif., Feb. 24, 2025 /PRNewswire/ — Aptitude Medical Systems, Inc. (Aptitude) today announced it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug ...
The Food and Drug Administration is making it easier for people to simultaneously test themselves for COVID-19 and the flu at home. The agency this week authorized the Healgen Scientific's Rapid Check ...
Medicare Part B covers COVID-19 tests when conducted in laboratories. Part A may cover lab tests if needed in hospital or skilled nursing facility settings. Since 2023, Medicare has no longer covered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results